Efficacy of Anifrolumab Across Multiple Organ Systems in Patients with Moderate to Severe Systemic Lupus Erythematosus: A Post-Hoc Analysis of the Phase III AZALEA trial (ACR Convergence 2026) - Sep 8, 2026 - Abstract #2200; Pres time: Nov 10, 2026; 10:30 AM - 12:30 PM; Location: WB1&2; In Person; No abstract available
Clinical • P3 data • Retrospective data • Immunology • Inflammatory Arthritis • Lupus • Systemic Lupus Erythematosus
|